Research demonstrates that APS can alter the differentiation and function of myeloid-derived suppressor cells (MDSCs) (62) and potentially attenuate regulatory T cell (Treg) recruitment, possibly via inhibition of Foxp3 expression (63). The gene discussed is FOXP3; the disease is autoimmune polyendocrinopathy.